spacer
home > epc > Spring 2002
PUBLICATIONS

European Pharmaceutical Contractor

epc
Spring 2002
At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. EPC provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of pharmaceuticals, take a look below at the range of articles featured in this issue of EPC
   
Text
PDF
bullet
introduction
In his Editor's Letter, Dr Graham Hughes reviews the articles in this Spring issue of EPC  
view
bullet
Marketplace & Business
Wayne Griffin, Managing Director of Acumen Pharmaceutical Services Ltd, predicts the effects that the implementation of the EU Clinical Trials Directive will have across member states in UK Phase I/IIa CROs - The Challenges Ahead  
view
All too often, British biotechs look to America for partnership in drug discovery and development. Philip Oliver, International Technology Promoter, Life Sciences - Europe, explains that partnering opportunities exist closer to home in UK and European Biotechs - Partnering for Profit  
view
In their Annual Review of Contract Research Organisations, Dr Graham Hughes, Scientific Director of Technomark Consulting Services Ltd, and Marianne O'Neill, Manager of Technomark Research, conclude that in spite of the tough times, the CRO industry is alive and well  
view
In recent years the pharmaceutical industry has become ever more competitive and it faces several major challenges in the 21st Century. Dr Faiz Kermani and Dr Gordon Findlay of CMR International offer some guidelines for Understanding Recent Trends in Pharmaceutical R&D  
view
bullet
Clinical Trials
Analysts believe that the Internet will transform clinical trials into an efficient exchange of electronic communication and data analysis. Paul Webb, Commercial and Operations Director, and Nigel Trim, Managing Director of MATRIX Contract Research Limited, consider the Transformation from Paper to Electronic Clinical Trials - The Site Perspective  
view
Marcin Dudek, Director of Clinical Operations and Dr Aneta Sitarska-Haber, Clinical Research Manager at Kiecana Clinical Research in Poland, examine the growth of registered trials in CEE countries and explain Why it is Worth Conducting Clinical Trials in Poland  
view
In Clinical Trials and New Drug Applications in Japan, Tony Mitchell, Director of Regulatory Affairs at Origin Pharmaceutical Services Limited, discusses the changes in the Japanese regulatory framework which have led to more effective, transparent and manageable approval processes  
view
bullet
Legal & Regulatory
Parallel trade is a relatively young yet highly controversial industry sector that is breaking free from the confines of the EU and taking a foothold in non-EU countries. Tim Atkinson, an Independent Biopharmaceutical Analyst, explores Global Parallel Trade - A Growing Concern  
view
In Medical Devices Exposed, David Wright, Managing Director/Director of Clinical and Regulatory, and Richard Wyse, Medical Director, at Celsus Ltd., highlight the European regulations for medical devices that companies must now meet before placing their products on the EC market  
view
bullet
Drug Discovery, Development & Delivery
Professor Chris Atterwill, Director of the Biosciences Group at Huntingdon Life Sciences looks at In Vitro Preclinical Lead Optimisation Technologies (PLOTs) in Pharmaceutical Development and explains that there is a need for early, rapid and robust screening assays which will allow a lead series of compounds to be ranked for desirable or undesirable characteristics  
view
In Peptide Pharmaceuticals Manufacturing - Making Fmoc Solid Phase Synthesis The Preferred Route, Kevin Price, Business Manager of the Peptide Pharmaceutical Business within Avecia Biotechnology, predicts that the Human Genome Project coupled with proteomics will lead to large numbers of new peptide and protein drug candidates  
view
In recent years there have been a number of developments indicating that testing in the future may not rely so heavily on animals. C. Deegan and M. Thomas of SafePharm Laboratories suggest some Alternatives to Animals for Toxicity Testing  
view
bullet
Patient Recruitment
In The Importance of Market Research in Patient Recruitment, Dr Diana Anderson, President & Chief Executive Officer at Rheumatology Research International, explains that when developing a campaign it is crucial to understand what motivates patients to participate in a clinical trial

 
view
bullet
DIA EUROMEETING PREVIEW
Richard Barrett of Pfizer Global Research and Development, UK, previews the Drug Information Association's 14th Annual EuroMeeting - Basel, Switzerland, 5th-8th March 2002  
view
bullet
Science & Innovation
There is a poor appreciation of the importance of adult tissue stem cells in normal tissue homeostasis and how drugs can affect their behaviour. In Stem Cells - The Clinician's 'Philosopher's Stone', Professor Christopher Potten, Founder of EpiStem Ltd, emphasises that to ignore stem cell effects is akin to treating the symptoms rather than the cause of disease  
view
Thomas Vorre-Grшntved MSc, Business Development Manager, Pharma and Diagnostic Production at Nunc A/S in Denmark, looks at Implementing New and Old Technologies - A Dedicated Strategy in Developing a Microarray Technology  
view
bullet
LABS & Logistics
In anticipation of future regulations, pharmaceutical companies are reviewing their 'cold chain' and temperature controlled processes. Mario Johnson, Pharmaceutical Industry Development Manager for DHL UK offers some advice on Ensuring Adequate Temperature Controlled Distribution - Regulations, Recommendations and Technology  
view
bullet
DATA MANAGEMENT
Andre Grigjanis, Managing Director, Global Competence Centre for IBS Pharma, and John O'Connor, Vice President Global Sales, the IBS Group highlight the benefits of integrated software that cover the full spectrum of the pharmaceutical industry's requirements, in Industry-Specific Supply Chain Software - The Sugar that Helps the Medicine Go Down  
view
User acceptance is among the greatest concerns a study sponsor has when implementing EDC. Thomas Haskell, Director of Product Management at CB Technologies offers some tips on What You Should Expect from a User-Friendly EDC Solution  
view
In Convergent Technologies - Opportunities in Clinical Trials, Kris Gustafson, Director of Interactive Technologies, and Joanna Williams, IVRS Project Director for ICON Clinical Research, advise clinical trials managers to take advantage of the convergence of various user interface management technologies  
view
David Gingell, Marketing Director, EMEA of Documentum Inc. explains how a late arrival to the e-business world will in fact provide the pharmaceutical industry with significant advantages, in Content Management - The Competitive Edge for e-Business Winners in the Pharmaceutical Industry  
view
Simon Crowe, Senior Business Development Manager, Informatics & Technology Services, PPD Development, UK emphasises the importance of planning, time considerations, process change, education and training in Maintaining Validation Control Over EDC Systems During a Clinical Study  
view
   
spacer



Published quarterly in
February, May,
August and November

News and Press Releases

Arquer Diagnostics Appoints Nadia Whittley as CEO


More info >>

White Papers

Bio/Pharmaceutical Methods: Do your Analytical Methods Hold Up to Regulatory Scrutiny?

Eurofins BioPharma Product Testing

As FDA guidelines evolve and drug products on the market begin to age, bio/pharmaceutical manufacturers face scrutiny of the original methods used to support these products. Therefore, manufacturers must re-evaluate these methods to ensure they comply with current FDA expectations. Some manufacturers are even facing consent decrees imposed by the agency requiring them to bring methods up to current standards within a specified timeframe. This exercise requires significant amounts of time and resources, which many manufacturers do not have since they are focused on getting their next products to market. For that reason, some clients have been turning to Eurofins Lancaster Laboratories for support.
More info >>

Industry Events

ManuPharma 2017

6-7 December 2017, Steigenberger Frankfurter Hof, Frankfurt

Europe's first peer-led pharma event for Heads of Tech Ops, Heads of Manufacturing Ops and Site Leads.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement